International Journal of Clinical Pharmacy This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Intraclass comparison of inhaled corticosteroids for the risk of pneumonia in chronic obstructive pulmonary airway disorder: a network meta-analysis and meta-regression
ConclusionICS class differences in pneumonia risk were observed in terms of pooled effect estimates but it is unlikely that any clinically relevant differences exist. Risk –benefit analysis supports ICS use in moderate-severe COPD. (Source: International Journal of Clinical Pharmacy)
Source: International Journal of Clinical Pharmacy - April 25, 2024 Category: Drugs & Pharmacology Source Type: research

The role of community pharmacists and pharmacies in physical activity promotion: an interdisciplinary e-Delphi study
ConclusionThis study endorses a set of roles for physical activity promotion in community pharmacy from an interdisciplinary perspective. Consensually established perspectives can inform policy making and practice, streamlining the coordination of pharmacies with the national health service. (Source: International Journal of Clinical Pharmacy)
Source: International Journal of Clinical Pharmacy - April 25, 2024 Category: Drugs & Pharmacology Source Type: research

Delabeling of allergy to beta-lactam antibiotics in hospitalized patients: a prospective study evaluating cost savings
ConclusionDelabeling hospitalized patients represents a cost-saving measure for treating patients labeled as allergic to beta-lactams. (Source: International Journal of Clinical Pharmacy)
Source: International Journal of Clinical Pharmacy - April 20, 2024 Category: Drugs & Pharmacology Source Type: research

Cost-effectiveness analysis of fruquintinib in Chinese patients with refractory metastatic colorectal cancer
ConclusionFruquintinib emerges as a promising therapeutic option for refractory mCRC. However, its cost-effectiveness depends on selected willingness-to-pay (WTP) threshold. While the drug ’s ICER surpasses the WTP based on China's 2022 GDP per capita, it remains below the threshold set at three times the national GDP. (Source: International Journal of Clinical Pharmacy)
Source: International Journal of Clinical Pharmacy - April 20, 2024 Category: Drugs & Pharmacology Source Type: research

Clinical impact of an individualised clinical pharmacy programme into the memory care pathway of older people: an observational study
ConclusionThe integration of clinical pharmacist secured the Memory care pathway of older patients with a cognitive complaint by identifying an important number of DRPs and PIMs with potential cognitive iatrogenic risk. (Source: International Journal of Clinical Pharmacy)
Source: International Journal of Clinical Pharmacy - April 20, 2024 Category: Drugs & Pharmacology Source Type: research

Assessing feasibility of conducting medication review with follow-up among older adults at community pharmacy: a pilot randomised controlled trial
ConclusionMedication review with follow-up is potentialy practical in community pharmacies, but there are feasibility issues. While these challenges can be addressed, it is essential to study larger sample sizes to establish more robust evidence regarding outcomes.Clinical trial registry: ClinicalTrials.Gov NCT05297461. (Source: International Journal of Clinical Pharmacy)
Source: International Journal of Clinical Pharmacy - April 18, 2024 Category: Drugs & Pharmacology Source Type: research

Exploring the impact of anticholinergic burden on urinary independence: insights from a post-stroke cohort of older adults
ConclusionIncreased anticholinergic burden in post-stroke patients who require assistance with urination is significantly associated with less independent urination. Anticholinergic agents may need to be introduced cautiously in patients who require assistance with urination. (Source: International Journal of Clinical Pharmacy)
Source: International Journal of Clinical Pharmacy - April 18, 2024 Category: Drugs & Pharmacology Source Type: research

Adverse events of nivolumab plus ipilimumab versus nivolumab plus cabozantinib: a real-world pharmacovigilance study
ConclusionOur findings contribute to the selection and clinical management of NIVO-IPI and NIVO-CABO, which minimizes the risk of AEs for individual patients with mRCC by considering distinctive differences in the AE profiles. (Source: International Journal of Clinical Pharmacy)
Source: International Journal of Clinical Pharmacy - April 17, 2024 Category: Drugs & Pharmacology Source Type: research

A systematic review of the impact of simulation on students ’ confidence in performing clinical pharmacy activities
ConclusionSimulation-based training generally yielded positive impact on improving pharmacy students ’ confidence in performing clinical pharmacy activities. Rigorous assessment methods and validated confidence questionnaires should be developed for future studies. (Source: International Journal of Clinical Pharmacy)
Source: International Journal of Clinical Pharmacy - April 17, 2024 Category: Drugs & Pharmacology Source Type: research

Author Correction: Assessing safety concerns of interstitial lung disease associated with antibody-drug conjugates: a real-world pharmacovigilance evaluation of the FDA adverse event reporting system
(Source: International Journal of Clinical Pharmacy)
Source: International Journal of Clinical Pharmacy - April 17, 2024 Category: Drugs & Pharmacology Source Type: research